<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:npr="https://www.npr.org/rss/" xmlns:nprml="https://api.npr.org/nprml" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
  <channel>
    <title>NPR: multiple sclerosis</title>
    <link>https://www.npr.org/templates/story/story.php?storyId=134948323</link>
    <description>multiple sclerosis</description>
    <language>en</language>
    <copyright>Copyright 2024 NPR - For Personal Use Only</copyright>
    <generator>Story API Shim 1.2.24</generator>
    <lastBuildDate>Wed, 09 Apr 2025 05:20:16 -0400</lastBuildDate>
    <image>
      <url>https://media.npr.org/images/podcasts/primary/npr_generic_image_300.jpg?s=200</url>
      <title>NPR: multiple sclerosis</title>
      <link>https://www.npr.org/tags/134948323/multiple-sclerosis</link>
    </image>
    <item>
      <title>Vagus nerve stimulation may tame autoimmune diseases</title>
      <description>The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the vagus nerve.</description>
      <pubDate>Mon, 03 Feb 2025 05:00:47 -0500</pubDate>
      <link>https://www.npr.org/sections/shots-health-news/2025/02/03/nx-s1-5272748/vagus-nerve-stimulation-may-tame-autoimmune-diseases</link>
      <guid>https://www.npr.org/sections/shots-health-news/2025/02/03/nx-s1-5272748/vagus-nerve-stimulation-may-tame-autoimmune-diseases</guid>
      <content:encoded><![CDATA[<img src='https://npr.brightspotcdn.com/dims3/default/strip/false/crop/2309x1299+0+0/resize/2309x1299!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F69%2F99%2Fab684c26495a87a93dcdc3e4e0c1%2Fgettyimages-1607085085.jpg' alt='An illustration of the Vagus nerve, which is part of the autonomic nervous system.'/><p>The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the vagus nerve.</p><p>(Image credit: Sebastian Kaulitzki/Science Photo Library RF)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=nx-s1-5272748' />]]></content:encoded>
      <dc:creator>Jon Hamilton</dc:creator>
    </item>
    <item>
      <title>What is multiple sclerosis, the illness causing Selma Blair&apos;s early &apos;Dancing&apos; exit?</title>
      <description>The actress Blair has been competing on the dance show for the past four weeks, but bowed out due to doctors&apos; orders regarding her multiple sclerosis illness.</description>
      <pubDate>Wed, 19 Oct 2022 04:01:25 -0400</pubDate>
      <link>https://www.npr.org/2022/10/19/1129845834/selma-blair-dancing-with-the-stars-multiple-sclerosis</link>
      <guid>https://www.npr.org/2022/10/19/1129845834/selma-blair-dancing-with-the-stars-multiple-sclerosis</guid>
      <content:encoded><![CDATA[<p>The actress Blair has been competing on the dance show for the past four weeks, but bowed out due to doctors' orders regarding her multiple sclerosis illness.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1129845834' />]]></content:encoded>
      <dc:creator>Ayana Archie</dc:creator>
    </item>
    <item>
      <title>Researchers Link Autism To A System That Insulates Brain Wiring</title>
      <description>Brains affected by autism appear to share a problem with cells that make myelin, the insulating coating surrounding nerve fibers that controls the speed at which the fibers convey electrical signals.</description>
      <pubDate>Mon, 03 Feb 2020 17:34:00 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2020/02/03/802215344/researchers-link-autism-to-a-system-that-insulates-brain-wiring</link>
      <guid>https://www.npr.org/sections/health-shots/2020/02/03/802215344/researchers-link-autism-to-a-system-that-insulates-brain-wiring</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2020/02/03/myelin-1_custom-81c16a11c5f15e60f4eb36d05d0ad52a4a528162.jpg' alt='This image from an electron microscope shows a cross-sectional view of an oligodendrocyte (blue) among nerve fibers coated with myelin (dark red). In models of autism spectrum disorder, oligodendrocytes appear to create too much or too little myelin.'/><p>Brains affected by autism appear to share a problem with cells that make myelin, the insulating coating surrounding nerve fibers that controls the speed at which the fibers convey electrical signals.</p><p>(Image credit: Jose Luis Calvo)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=802215344' />]]></content:encoded>
      <dc:creator>Jon Hamilton</dc:creator>
    </item>
    <item>
      <title>Patients Still Struggle To Balance High Costs Of MS Treatment, Despite Generic</title>
      <description>Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here&apos;s why.</description>
      <pubDate>Mon, 20 Jan 2020 09:00:00 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2020/01/20/797477657/patients-still-struggle-to-balance-high-costs-of-ms-treatment-despite-generic</link>
      <guid>https://www.npr.org/sections/health-shots/2020/01/20/797477657/patients-still-struggle-to-balance-high-costs-of-ms-treatment-despite-generic</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2020/01/17/gettyimages-173291518-a6768e9d6ce70d23789238876184366dd2e0d3c4.jpg' alt='Generics may not have the same cost-lowering power for specialty medicines, such as multiple sclerosis drugs, researchers find. That's true especially when other brand-name drugs are approved to treat a given disease before the first generic is approved.'/><p>Drugs to treat multiple sclerosis can run $70,000 a year or more. Patients hoped competition from a generic version of one of the most popular brands would spur relief, but prices went up. Here's why.</p><p>(Image credit: Gary Waters)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=797477657' />]]></content:encoded>
      <dc:creator>Sydney Lupkin</dc:creator>
    </item>
    <item>
      <title>Researchers Find A Web Of Factors Behind Multiple Sclerosis</title>
      <description>It&apos;s looking like MS strikes when a variety of triggers gang up to impair neurons in the brain and spinal cord. Researchers are using their new knowledge to search for treatments.</description>
      <pubDate>Mon, 21 Jan 2019 08:35:00 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2019/01/21/684495345/researchers-find-a-web-of-factors-behind-multiple-sclerosis</link>
      <guid>https://www.npr.org/sections/health-shots/2019/01/21/684495345/researchers-find-a-web-of-factors-behind-multiple-sclerosis</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2019/01/11/sciencesource_ss2116333_custom-7ca49834fdf8d61953dc29b4e4275273667f9ccc.jpg' alt='A scanning electron micrograph shows microglial cells (yellow) ingesting branched oligodendrocyte cells (purple), a process thought to occur in multiple sclerosis. Oligodendrocytes form insulating myelin sheaths around nerve axons in the central nervous system.'/><p>It's looking like MS strikes when a variety of triggers gang up to impair neurons in the brain and spinal cord. Researchers are using their new knowledge to search for treatments.</p><p>(Image credit: Dr. John Zajicek)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=684495345' />]]></content:encoded>
      <dc:creator>Bret Stetka</dc:creator>
    </item>
    <item>
      <title>Crowdfunding Drives Funds And Attention Toward Questionable Medical Treatments</title>
      <description>Many Americans turn to crowdfunding to pay for medical care. But sometimes the money covers unproven treatments. Should crowdfunding companies be held accountable for spreading false hopes?</description>
      <pubDate>Wed, 02 Jan 2019 05:00:51 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2019/01/02/674385287/crowdfunding-drives-funds-and-attention-toward-questionable-medical-treatments</link>
      <guid>https://www.npr.org/sections/health-shots/2019/01/02/674385287/crowdfunding-drives-funds-and-attention-toward-questionable-medical-treatments</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2018/12/06/npr-medical-fundraising_sara-wong-update_wide-5174f88a88a8500df0772f0c3acd23b908dde751.jpeg' alt='undefined'/><p>Many Americans turn to crowdfunding to pay for medical care. But sometimes the money covers unproven treatments. Should crowdfunding companies be held accountable for spreading false hopes?</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=674385287' />]]></content:encoded>
      <dc:creator>Rachel D. Cohen</dc:creator>
    </item>
    <item>
      <title>Chronically Ill, Traumatically Billed: $123,019 For 2 Multiple Sclerosis Treatments</title>
      <description>Shereese Hickson&apos;s doctor wanted her to try a drug called Ocrevus for her multiple sclerosis. Trained as a medical billing coder, Hickson was shocked by the six-figure bill and the share she owed.</description>
      <pubDate>Tue, 27 Nov 2018 13:41:00 -0500</pubDate>
      <link>https://www.npr.org/sections/health-shots/2018/11/27/668663222/chronically-ill-traumatically-billed-123-019-for-2-multiple-sclerosis-treatments</link>
      <guid>https://www.npr.org/sections/health-shots/2018/11/27/668663222/chronically-ill-traumatically-billed-123-019-for-2-multiple-sclerosis-treatments</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2018/11/26/hickson_09_custom-55f2375e1d23577cd3cd9cd85cb8a6568b970d7b.jpg' alt='Shereese Hickson was diagnosed with multiple sclerosis in 2012 and is unable to work. She supports herself and her son, Isaiah, on $770 a month.'/><p>Shereese Hickson's doctor wanted her to try a drug called Ocrevus for her multiple sclerosis. Trained as a medical billing coder, Hickson was shocked by the six-figure bill and the share she owed.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=668663222' />]]></content:encoded>
      <dc:creator>Jay Hancock</dc:creator>
    </item>
    <item>
      <title>Has Genetic Privacy Been Strained By Trump&apos;s Recent ACA Moves?</title>
      <description>As the Trump administration decides not to defend the Affordable Care Act&apos;s legal protections for people with pre-existing conditions, questions arise about health insurance and genetic information.</description>
      <pubDate>Wed, 11 Jul 2018 08:02:47 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2018/07/11/627287642/has-genetic-privacy-been-strained-by-trumps-recent-aca-moves</link>
      <guid>https://www.npr.org/sections/health-shots/2018/07/11/627287642/has-genetic-privacy-been-strained-by-trumps-recent-aca-moves</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2018/07/09/gettyimages-758294397-1-_wide-5ce75290a716c7ea83854fd3194511bfb92bbc95.jpg' alt='The Genetic Information Nondiscrimination Act still prohibits your insurer from using the results of genetic tests against you. But the ACA's additional protections may be in doubt if certain states get their way.'/><p>As the Trump administration decides not to defend the Affordable Care Act's legal protections for people with pre-existing conditions, questions arise about health insurance and genetic information.</p><p>(Image credit: Gary Waters)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=627287642' />]]></content:encoded>
      <dc:creator>Michelle Andrews</dc:creator>
    </item>
    <item>
      <title>Why Some Patients Getting Drugmakers&apos; Help Are Paying More</title>
      <description>Some health plans are refusing to count the copayment assistance offered by drugmakers as part of a patient&apos;s deductible. That means some patients are paying thousands of dollars more out-of-pocket.</description>
      <pubDate>Wed, 30 May 2018 05:00:08 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2018/05/30/615156632/why-some-patients-getting-drugmakers-help-are-paying-more</link>
      <guid>https://www.npr.org/sections/health-shots/2018/05/30/615156632/why-some-patients-getting-drugmakers-help-are-paying-more</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2018/05/29/gettyimages-941741224-be99f58566e2ac266c6c536d0cbc7fe019f14b91.jpg' alt='As the price of specialty drugs continues to rise, some health plans are shifting more of the cost to patients.'/><p>Some health plans are refusing to count the copayment assistance offered by drugmakers as part of a patient's deductible. That means some patients are paying thousands of dollars more out-of-pocket.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=615156632' />]]></content:encoded>
      <dc:creator>Michelle Andrews</dc:creator>
    </item>
    <item>
      <title>For One Father And Son In Puerto Rico, A Storm Was Just The Latest Trial</title>
      <description>The Martinez family has been waiting more than a year for a neurologist to diagnose the son&apos;s condition. He needs a diagnosis to be eligible for the health care he needs, but can&apos;t get an appointment.</description>
      <pubDate>Thu, 22 Mar 2018 15:46:00 -0400</pubDate>
      <link>https://www.npr.org/sections/health-shots/2018/03/22/594890392/for-one-father-and-son-in-puerto-rico-a-storm-was-just-the-latest-trial</link>
      <guid>https://www.npr.org/sections/health-shots/2018/03/22/594890392/for-one-father-and-son-in-puerto-rico-a-storm-was-just-the-latest-trial</guid>
      <content:encoded><![CDATA[<img src='https://media.npr.org/assets/img/2018/03/19/puerto-rico-2-8d0aef96de7674ea57d37c74e04e0311244ef984.jpg' alt='Dr. Carla Rossotti (left), a general practitioner, and her health care team leave the home of the their patient, 37-year-old Osvaldo Daniel Martinez. He has the symptoms of a degenerative disease, Rossotti says, but he needs a neurologist's evaluation before he can get proper treatment.'/><p>The Martinez family has been waiting more than a year for a neurologist to diagnose the son's condition. He needs a diagnosis to be eligible for the health care he needs, but can't get an appointment.</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=594890392' />]]></content:encoded>
      <dc:creator>Sarah Varney</dc:creator>
    </item>
  </channel>
</rss>